Th e cardiovascular control involves a bidirectional functional connection between the brain and heart. We hypothesize that this connection could be extended to other organs using endocrine and autonomic nervous systems (ANS) as communication pathways. Th is implies a neuroendocrine interaction controlling particularly the cardiovascular function where the enzymatic cascade of the renin-angiotensin system (RAS) plays an essential role. It acts not only through its classic endocrine connection but also the ANS. In addition, the brain is functionally, anatomically, and neurochemically asymmetric. Moreover, this asymmetry goes even beyond the brain and it includes both sides of the peripheral nervous and neuroendocrine systems. We revised the available information and analyze the asymmetrical neuroendocrine bidirectional interaction for the cardiovascular control. Negative and positive correlations involving the RAS have been observed between brain, heart, kidney, gut, and plasma in physiologic and pathologic conditions. Th e central role of the peptides and enzymes of the RAS within this neurovisceral communication, as well as the importance of the asymmetrical distribution of the various RAS components in the pathologies involving this connection, are particularly discussed. In conclusion, there are numerous evidences supporting the existence of a neurovisceral connection with multiorgan involvement that controls, among others, the cardiovascular function. Th is connection is asymmetrically organized.
More than 150 years ago, Claude Bernard already proposed a bidirectional neurovisceral integration between the brain and heart: "Consequently, heart and brain fi nd themselves in an interdependence of mutual intimated action, which is multiplied and reinforced as the organism is growing in sophistication and developing" (Bernard 1878). Recently, this concept was extended and interpreted as a neurovisceral integration model (NIM) (Th ayer and Lane 2009) . Each individual has a distinctive variability between the beats that make up the heart rate (HRV). Th ayer and Lane (2009) have proposed that the HRV that is controlled by the autonomic nervous system (ANS) could be not only an index of the cardiac function but also an index of the degree to which the brain, as an integrating center, generates an adaptive peripheral body's response to environmental changes.
Th e present review is a compilation that integrates the main data regarding neurovisceral interactions with the data supporting that such interactions may be bidirectionally organized in an asymmetrical way. Th ose neurovisceral interactions are well known but the mechanisms underlying such as communications are not understood. Clearly, the asymmetry in brain functions may determine the bidirectional asymmetric communications. However other mechanisms, for example asymmetries in paired peripheral organs including adrenals, kidneys or gonads, and also in the bilateral autonomic innervation of odd organs such as heart, may be involved in the bidirectional asymmetric organization of the information transfer.
Th e prefrontal cortex and subcortical areas such as the amygdala form a reciprocal inhibitory circuit (Shoemaker and Goswami 2015) , the function of which is to regulate the behavioral and emotional responses to adapt the body to environmental demands and control the function of the ANS aff ecting the heart and other organs (Williams et al. 2015) . Th ese authors have suggested that this circuit could serve as a connection (mediated by the ANS) between the emotional and physiological processes and that its level of activity could be monitored by the HRV. Th ey have proposed that the HRV represents a psychophysiologic index regulated by the ANS and associated with the emotional control capability predicting emotional diffi culties (Williams et al. 2015) .
However, the concept of the neurovisceral integration could be extended including especially the heart and kidney (Prieto et al. 2014a) , adrenals (Prieto et al. 1998) , blood (Segarra et al. 2012 , and even gut with its microbiota (Jose and Raj 2015; Grenham et al. 2011) , all being involved in the cardiovascular control (CVC). Such a large connection would mainly involve the ANS and the endocrine system. Th is connection implicates a bidirectional neuroendocrine interaction between the brain and peripheral organs regulating the vital physiologic processes for survival such as glucose metabolism or CVC (Prieto et al. 2014a; McCraty and Shaff er 2015; Ramsay and Woods 2014) , as well as a coordinated global response under stress. Th is integrative response would involve interactions between diff erent central areas, such as prefrontal cortex (PFC), amygdala (AM) or hippocampus (HC) (Hernandez et al. 2015) , as well as bidirectional interactions between some of these areas and peripheral tissues or blood (Segarra et al. 2012 , in which the renin-angiotensin system (RAS) would play a major role.
Th e RAS in the neurovisceral communication
Th e RAS plays a key role in the bidirectional integration for CVC. In this system (outlined in Figure 1 ) , several aminopeptidases, generically called angiotensinases, play the major role in the metabolism of the various angiotensin (Ang) peptides. Th e study of their regulation has become an important line of research not only to better understand the function of the RAS but also develop new diagnostic and therapeutic tools for cardiovascular diseases using activators or inhibitors of such enzymes (Gao et al. 2014) .
Th e RAS is crucial in the homeostatic control of body processes. Particularly, brain Ang II (Saavedra 2012) facilitates the stress response whereas other component such as Ang 1-7 or Ang IV, inhibit that reaction (Fontes et al. 2016) . Th e homeostatic response depends on the analysis of the sensory information by central areas to elaborate a motor response conveyed by the ANS in order to quickly get eff ective control of the target organs. ANS disturbances lead to cardiovascular disability as severe as it can even cause sudden death (Soros and Hachinski 2012) . Th e ANS control depends not only on the brainstem function but also on aff erent signals that come from the cortical and limbic areas .
Th e kidney contains sensory aff erent and eff erent sympathetic fi bers (Booth et al. 2015) . Changes in sympathetic activity modulate the renal mechanisms causing hypertension (Grisk 2005) . In heart failure (HF), there is a cardiac and renal eff erent sympathetic activation. However, while the eff erent sympathetic activity clearly increased renal vasoconstriction, renin release, and sodium retention, the sensory aff erent activity has been poorly studied. In fact, the benefi cial eff ects of renal denervation in HF are unclear: it could be due to a denervation of either an eff erent sympathetic component or alteration of the sensitive aff erent pathway or also a combination of both (Booth et al. 2015) . Experimental studies in favor of a renal sensory aff erent activation have been reported by Xu et al. (2012) who have observed that rostral ventrolateral medulla projecting neurons to paraventricular nucleus were more active in rats with chronic HF leading to sympathetic nerve activation (SNA). In addition, the inhibitory reno-renal refl ex is blunted in HF, which may also stimulate SNA (Kopp et al. 2003) .
Clearly, the RAS plays an essential role in the cardiovascular and renal function and its study has revealed new surprising results suggesting its participation in the mentioned bidirectional neurovisceral integration for CVC. Prieto et al. (2014a) have studied the infl uence of L-NAME (sympathetic stimulation) or propranolol (sympathetic blockade) treatment on angiotensinase activities in the hypothalamus (HT), left ventricle (VT), renal cortex (RC), and re-nal medulla (RM) of normotensive Wistar-Kyoto and spontaneously hypertensive rats (SHR). Results have revealed a high incidence of highly signifi cant correlations between angiotensinase activities when these tissues were compared. Th e correlations observed in such studies not only allowed to discriminate between the activation of the sympathetic or parasympathetic systems but also hypothesize the participation of the angiotensinases and consequently the RAS in the mechanisms that bidirectionally connect brain, heart, and kidney for CVC. In SHR, sympathetic hyperactivation with a negative relationship of angiotensinases between HT and VT and a positive one between HT and RC could be suggested aft er L-NAME treatment (Figure 2 ). It should be noted that these relationships could not only involve the classical endocrine RAS connection but also other types of communication systems with the various components of the RAS, which could travel bidirectionally through the ANS. It has been hypothesized that the mechanisms, by which this communication takes place, could involve retro-control processes not yet clearly identifi ed. For example, the existence of a bidirectional axonal transport involving various components of the RAS such as angiotensin-converting enzyme (Kato et al. 1987; Aiso et al. 1988) , Ang II binding sites through the vagus nerve (Diz and Ferrario 1988) or angiotensinases (Prieto et al. 2014a ) Figure 1 . Th e proteolytic enzymes (angiotensinases) of the renin-angiotensin system (RAS) are responsible for generating diff erent peptides with diff erent functions. Angiotensin (Ang) I (1-10) is produced by the activity of renin on its inactive precursor Angiotensinogen. Th e angiotensin converting enzyme (ACE) is responsible for the Ang II (Ang 1-8) formation which is further metabolized to Ang III (Ang 2-8) by glutamyl aminopeptidase (AP A). Alternatively, Ang I may be metabolized to other active peptides depending on the enzyme involved. Aspartyl-aminopeptidase (AspAP) hydrolyzes the Asp amino-terminal to produce Ang 2-10, which could be further converted to Ang III by the action of ACE. Furthermore, Ang I may be converted to Ang 1-7 by neutral endopeptidase (NEP) or to Ang 1-9 by the ACE homologous ACE 2. Ang 1-9 could be further converted to Ang 1-7 by ACE. Ang III could be metabolized to Ang IV (Ang 3-8) through the action of either arginyl-aminopeptidase (AP B) or alanyl-aminopeptidase (AP M). Ang IV is further converted to Ang 4-8 again by the action of AP M and then converted to Ang 5-8 by the activity of the adipocytederived leucine aminopeptidase (A-LAP). Th e AT 1 receptor binds essentially Ang II but also Ang III with a lower affi nity; the AT 2 receptor binds mostly Ang III and Ang II but also Ang 1-9; the AT 4 receptor binds specifi cally Ang IV whereas the Mas-receptor binds exclusively Ang 1-7 . Th e thickness of the arrow indicates the degree of affi nity for the receptor.
has been suggested. Furthermore, it has been hypothesized that the ANS could participate in the regulation of secretory mechanisms for angiotensinases in the neuro-eff ector junctions, either directly from the eff erent nerve terminals or secreted from the tissues themselves under their activation through autonomic nerve terminals (Prieto et al. 2014a; Banegas et al. 2009 ). Aff erent neurons could also carry angiotensinases from target tissues to brain (Prieto et al. 2014a) (Figure 3 ). Because the cardiac and renal eff ects observed in the patients with essential hypertension have been faithfully reproduced in L-NAME treated hypertensive animals (Zhou and Frohlich 2007) , the high levels of correlation observed by Prieto et al. (2014a) among brain, heart, and kidney may refl ect to some extend the mechanisms associated with the severity of the cardio-renal damage of such patients. Th ese results could add valid information to clarify the aff erent and eff erent mechanisms involved in Th e continuous arrows show an increased turnover of RAS and the discontinuous one a decreased one. When the hypothalamic RAS turnover is increased, the ventricular is decreased and vice versa, when the ventricular RAS turnover is increased, the hypothalamic is decreased. In contrast, when the hypothalamic or renal RAS turnover is increased, the renal or hypothalamic will be too (Prieto et al. 2014a ).
Figure 3.
Drawing of a hypothetical model of neurovisceral integration in which, the renin-angiotensin system (RAS) would be involved through the autonomic nervous system (ANS) (Prieto et al. 2014a ). (A) Th e peptidergic precursors and proteolytic enzymes, synthesized by ribosomes of the rough endoplasmic reticulum, are moved through the cisterns of the reticulum until the Golgi apparatus where they will be stored, either coexisting or independently in secretory granules that will be transported through the axon, where presumably their processing take place by the action of proteases which, could also be co-transported in the same vesicles. (B), (C) and (D) Once in the nerve terminal or neuroeff ector junction, through a calcium-dependent mechanism, the vesicular content is released into the inter-synaptic or interstitial space. Coming up next, the peptide-receptor (post and/or presynaptic) interaction take place, thus leading to the cellular eff ect. Once carried out its action, the peptide will be inactivated or removed from the interstitial or inter-synaptic space through degradation by soluble or membrane-bound peptidases, by synaptic recapture or by internalization of the peptide-receptor complex with subsequent fusion of vesicles with enzymatic content (Hallberg 2015) . Th e functional status of angiotensins and angiotensinases in the neuroendocrine axis could be regulated by the ANS through feedback mechanisms not yet clearly established. It has been suggested and described, an anterograde and retrograde axonal transport for several components of the RAS such as angiotensinases, angiotensin II and its receptor (Prieto et al. 2014; Kato et al. 1987; Aiso et al. 1988; Diz and Ferrario 1988) . In addition, the ANS could regulate secretory processes for angiotensinases in the neuroeff ector junctions, either from nerve terminals or from the tissues themselves (Prieto et al. 2014). cardio-renal damage in hypertensive subjects which may lead to HF. Th is clearly implies the brain-heartkidney axis (Booth et al. 2015) . Angiotensinases are involved in the metabolism of the diff erent angiotensin peptides, inactivating and transforming them in new peptides with diff erent functions and properties (Figure 1 ) . Th erefore, the degree of these activities refl ects the level of the angiotensin substrates and the resulting biotransformed products.
Th erefore, we could speculate that the sympathetic hyperarousal in L-NAME treated hypertensive animals may lead to a parallel higher turnover (higher angiotensinase activities) of Angs in HT and RC, the functional status of both local hypothalamic and renal RAS being connected together via the sympathetic branch of the ANS (Prieto et al. 2014a ). However, the sympathetic hyperactivation in L-NAME treated rats would simultaneously lead to an inverse turnover of angiotensin peptides between the hypothalamus and the heart, whereas the angiotensinase activity increases in the hypothalamus and decreases in the heart (Figure 2 ). Th is may refl ect an imbalance of the functional status of the RAS between the hypothalamus and the heart and between the hypothalamuskidney and the hypothalamus-heart axes in the specifi c conditions following L-NAME treatment in SHR.
Th e gut in the neuroendocrine integration for the cardiovascular control
For CVC, there are integrative mechanisms that functionally connect not only the brain, heart or kidney, but also other tissues such as the gut and even its microbiota. For that reason, there are currently intense investigations on the role played by dietary factors, especially fats, in CVC (Michas et al. 2014; Villarejo et al. 2015) . Th e composition of the gut microbiota, conditioned by the type of diet, could hypothetically infl uence the brain function and participate in CVC not only through neural brainheart connections but also through factors produced by both the microbiota and the intestine (Ito and Adachi-Akahane 2013). Th us, diff erent types of diets diff erentially modify the gut microbiota (Hidalgo et al. 2014) , which infl uences the brain function (Grenham et al. 2011) . Moreover, diff erent types of diets diff erentially infl uence the cardiovascular function (involving the RAS) and the profi le of fatty acids and neuropeptides (including Angs) in the frontal cortex ) aff ecting the cortical functions. In fact, the absence of gut microbiota radically alters the nervous and neuroendocrine responses to stress (Crumeyrolle-Arias et al. 2014), suggesting a functional bidirectional relationship between the gut and the brain neuropeptides (Holzer and Farzi 2014) . Th is involves brain areas such as the hypothalamus, cortex and the limbic system (Bonaz 2013) . Th e abundance of Firmicutes and Bacteroidetes in the gut microbiota is associated with an increased blood pressure in several models of hypertension and decreased gut microbiota, following antibiotics treatments, may modulate blood pressure (BP) (Jose and Raj 2015) . However, to our knowledge, there are still no reports demonstrating direct eff ect of the gut microbiota and diet on CVC. Preliminary results have suggested, however, such infl uence (Prieto et al. 2014b ). Th ese authors have compared a diet enriched with butter with another supplemented with virgin olive oil. Whereas high butter diet produced a greater accumulation of visceral adipose tissue and higher BP levels, the diet supplemented with virgin olive oil was associated with lower levels of triglycerides in plasma, higher HDL/LDL ratio and lower BP. Th ese values correlated with the percentage of selective microbial groups suggesting that the benefi cial eff ects of virgin olive oil were linked to modulation of intestinal microbiota.
All these observations could be interlinked. Th e type of diet could modify the intestinal microbiota and infl uence the brain and cardiovascular function in an integrated manner in which autonomic and endocrine systems participate. All this falls within the scope of the neurovisceral integration, in which the nervous system, whose development can be infl uenced by the intestinal microbiota (Kabouridis and Pachnis 2015) , and the enteric endocrine system, including the classical APUD (amine precursor uptake and decarboxilation) system, could play a major role. Pearse and Polak (1971) proposed that APUD cells, where classic neurotransmitters and neuropeptides coexist, are originated from neural crest and interact with both autonomous and endocrine systems (Baylis et al. 1993) . Neuropeptides from cerebral and intestinal origin might be part of a functional unit that plays an important role in the establishing a bidirectional control (through ANS and endocrine system) between the involved tissues. Some neuropeptides involved are: substance P, neuropeptide Y, vasoactive intestinal polypeptide, somatostatin (Holzer and Farzi 2014), cholecystokinin (Dockray 2013) or Angs (Fandriks 2011) . Th e mechanisms by which these neuropeptides may connect bilaterally gut and brain not only include endocrine pathways and the stimulation of aff erent and eff erent neurons (Holzer and Farzi 2014) but also axonal transport of factors that infl uence both gut and brain. In fact, this type of connection is possible as vagal axonal transport of RAS components such as angiotensin II binding sites (Diz and Ferrario 1988) , as well as factors such as α-synuclein has been observed directly from gut to brain (Holmqvist et al. 2014) .
Finally, if the ANS works asymmetrically, it is presumable that this asymmetry also implies gut functions and some evidences may support this hypothesis. Indeed, a signifi cant negative association has been observed between left -handedness and early satiation (Fujiwara et al. 2011 ) and a positive one with infl ammatory bowel diseases (Morris et al. 2001) , in which Ang II is also involved (Fandriks 2011 ).
Brain asymmetry
Th e available data have shown that the asymmetry extends to all organizational levels of the main internal communication systems: brain structures, peripheral nervous system, and endocrine glands (Ramirez et al. 2004 ). Th us, one can consider neuropeptides in the brain structures and their regulatory enzymes (neuropeptidases, including angiotensinases). In the brain, there are asymmetries in the content of gonadotropin-releasing hormone that predominates in the right hypothalamus (Gerendai and Halasz 2001) . Also, thyrotropin-releasing hormone prevails in the left hypothalamus (Borson-Chazot et al. 1986 ). Furthermore, cholecystokinin-8 or angiotensin II facilitate learning and memory when microinjected respectively into the left amygdala (Belcheva et al. 1994) or hippocampus (Tashev and Stefanova 2015) . Several angiotensinases also show signifi cant inter-hemispheric diff erences in amygdala, hippocampus, and prefrontal cortex (Banegas et al. 2005) . Considering the peripheral nervous system and endocrine glands, one also observed a lateralization in reproductive functions where right brain structures apparently play a predominant role: indeed, right but not left vagotomy of testes and ovaries lead to increased levels in serum luteinizing hormone (Gerendai and Halasz 2001). In addition, it was reported that right, but not left prefrontal cortex, lesions decreased corticosterone levels in acutely stressed animals suggesting right hemisphere dominance in the control of the hypothalamic-pituitary-adrenal axis (Sullivan and Gratton 1999) . Th is involves a lateralization of the innervation of the paired endocrine glands, gonads, and adrenals, via the vagus nerve, which confer a key role to the right hemisphere in the control of autonomic functions in order to increase the chances of the subject survival (Gerendai and Halasz 2001) .
Finally, indirect data also suggest that angiotensinase activities act asymmetrically in the control of BP and water balance and this also involves the ANS (Prieto et al. 2014a) . Moreover, such asymmetry is not static but dynamic and adjustable depending on the variability in exogenous conditions such as light or dark conditions (Ramirez et al. 2004) or endogenous environment like type and level of sex steroids (Ramirez et al. 2008; Rueda et al. 2016) , stress (Lee et al. 2014 ), brain dopamine content (Banegas et al. 2009 or drug treatments involving the RAS, such as ACE inhibitors (Segarra et al. 2012 .
Asymmetry in the neuroendocrine interaction for the cardiovascular control
Th is section describes the major available data that may support a bidirectional asymmetry in the neurovisceral integration model for CVC. Th us, stroke aff ecting the left or right hemisphere is a major cause of disability and death (Rodgers 2013 ). Its prognosis is very serious and an early appropriate evaluation is essential to establish an eff ective treatment. Stroke usually involves alterations of the ANS (Klingelhofer and Sander 1997) . Physiologically, there is a neuroendocrine asymmetry that includes the ANS (Ramirez et al. 2004; Gerendai and Halasz 2001) . Studies in animals and humans have suggested that the generated disturbance is depending on the brain area and the injured side.
Th ese studies have highlighted the importance of the asymmetric organization of both central and peripheral nervous system in CVC. However, the results are confusing and sometimes apparently contradictory. Patients with lateralized neurological disorders develop myocardial problems. Th e pathogenesis of these disorders is still unknown and various hypotheses have been proposed. For example, a lateralized sympathetic activation with right predominance has been suggested aft er a right hemisphere stroke with increased serum levels of norepinephrine and cardiac arrhythmias (Sander and Klingelhofer 1995) . In animal models, insular lesions may cause cardiac arrhythmias. Something similar may happen in humans. While right insular stimulation activates the sympathetic cardiovascular tone, the left insular stimulation activates the parasympathetic one (Oppenheimer 2006) . It is worth, however to indicate that no clear predominant laterality on CVC or stroke prognosis in relation to insular cortex stroke has been reported in patients (Nagai et al. 2010) . On the other hand, under stress, heart disease correlates with an asymmetric hyperactivation of certain brain areas such as the left parietal cortex or the right visual association cortex (Soufer et al. 1998) . Inducing a stroke in genetically hypertensive rats with a diet containing 4% NaCl and 0.75% of K + , results in higher density of cerebrovascular sympathetic nerves in the left hemisphere than in the right (Smeda 1990 ). It has also been speculated that parasympathetic tone was reduced ipsilateral to the aff ected hemisphere linked to an increase in the sympathetic one of the same side (Lane et al. 1992) . Zamrini et al. (1990) have analyzed the heart rate in patients aft er the unilateral inactivation of hemispheres by intracarotid amobarbital administration. Th e heart rate increased or decreased aft er the inactivation of either the left or the right hemisphere, respectively suggesting the existence of anatomical or functional asymmetries in the central and peripheral nervous system. Also, occlusion of the left or right middle cerebral artery in normotensive rats reduces BP only in animals with left occlusion (Hachinski et al. 1992) . In these experiments, renal sympathetic nerve discharge increased aft er left occlusion (suggesting RAS activation) whereas plasma norepinephrine increased aft er right occlusion.
Additionally, hypertension has been associated with a vascular dementia and cognitive impairment. Chiefl y, one observes a direct relationship between the hypertension and atrophy of the left hemisphere in humans (Lis and Gaviria 1997) . It has also been noted that systolic BP tended to be higher and less stable aft er ischemic stroke located mainly in the left hemisphere (Dicker et al. 2006) . Studies in mice have suggested that the left cerebral ischemia produces cardiac dysfunction associated with extensive damage of insular cortex (Min et al. 2009 ). Furthermore, based on anatomical studies of the asymmetrical ways that originate from the dorsomedial nucleus of the left or right hypothalamus (Toga and Th ompson 2003), Xavier et al. (2013) studied the possible asymmetry in the cardiovascular responses to the stimulation of that nucleus. Th eir results have indicated that these pathways are asymmetric and that the right dorsomedial nucleus may exert a predominant control on the cardiovascular function in situations of emotional stress.
Other studies in normotensive and hypertensive rats have indicated a dramatic and progressive increase in BP in animals aft er left lesions of the nigrostriatal system with left hemisphere dopamine depletion of more than 90%. Th is was not accompanied by an increase in heart rate suggesting a change in the peripheral resistance rather than a contribution of the cardiac output . Th is again supports a functional asymmetry of the ANS in CVC. Moreover, unilateral lesions of the nigrostriatal system cause a change in plasma angiotensinases and nitric oxide (NO) content following vascular sympathetic activation, which again diff ers depending on the side of the brain lesion. Angiotensinase activities and NO concentration showed a negative plasma correlation in the right lesioned normotensive rats and left lesioned hypertensive ones, which also suggests an asymmetric control of the ANS in that response (Banegas et al. 2009 ). Hypertensive animals treated with the ACE inhibitor captopril showed a marked number of correlations between angiotensinase activities obtained in the right frontal cortex (but not in the left ) and the ventricle in comparison with nontreated control animals that fundamentally showed correlations between the ventricle and the left frontal cortex . In contrast, the existence of correlations between the plasma angiotensinase activities and right or left frontal cortex are reversed in animals treated or not treated with captopril. While in control animals, the angiotensinase activities correlated signifi cantly with the right frontal cortex, in animals treated with captopril, the correlations were with the left cortex (Segarra et al. 2012) . Th erefore, alterations of the RAS (i.e. ACE inhibition) asymmetrically modify the neuroendocrine response because they diff erentially aff ect both the left or right nervous system-heart axis and the left or right nervous system-blood axis. Rueda et al. (2016) have observed signifi cant diff erences in BP depending on the gender, handedness, the phase of the ovarian cycle, and the arm, in which the BP was determined. Th e authors have described higher levels of pressure in left -handers women during the menstrual phase. Th ey have also reported that the level of motor laterality correlated negatively with BP measured in the left arm of right-handers women in ovulatory phase but positively with the pressure measured in the right arm of the right-handers women in menstrual phase.
Conclusions
Th ere are abundant evidences supporting the existence of a neurovisceral connection with multiorgan involvement that controls, among others, the cardiovascular function. In addition, it is also obvious that the cardiovascular, nervous, and neuroendocrine functions are asymmetrically organized. Th erefore, it seems logical to think that this is also true for the neurovisceral integration. Such asymmetry is not only motor, cognitive or emotional but also autonomous and neuroendocrine involving the whole body.
Although available data does not allow establishing a general pattern for the bidirectional asymmetry in the cardiovascular control, one can speculate about inverse reciprocal interactions between the left and the right brain areas through modulation of the ANS and RAS.
Hypothetically, various types of unilateral lesions at several central and peripheral levels of the nervous system may lead to contralateral compensatory mechanisms that determine the cardiovascular response. Similarly, cardiac abnormalities may determine asymmetries in the central response that would be necessary to know in order to assess the prognosis and treatment not only for the cardiac disorders but also for its cognitive consequences. While multiple asymmetries in physiologic and pathologic conditions have been described, a direct relationship
has not yet been observed between the occurrence of a defi nite asymmetry or its basal modifi cation and the etiology of a given disease. We don't know whether these changes are a cause or a result of the disease. Th us, the search for the systematic patterns of asymmetric behaviors in health and disease will continue.
Further detailed development of our proposal may help in the diagnosis and prognosis of the severity of the pathological entity depending on the brain or the peripheral organ lesion's sides.
